Dark Forest Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,262
Closed -$273K 1010
2025
Q4
$273K Sell
9,262
-26,947
-74% -$732K 0.01% 888
2025
Q3
$935K Buy
+36,209
New +$1.01M 0.04% 764
2024
Q4
Sell
-3,047
Closed -$204K 1184
2024
Q3
$204K Buy
+3,047
New +$280K 0.03% 868
2022
Q3
Sell
-6
Closed -$1K 1327
2022
Q2
$1K Buy
+6
New +$858 ﹤0.01% 803
2021
Q4
Sell
-78
Closed -$30K 1660
2021
Q3
$30K Sell
78
-12
-13% -$4.43K 0.01% 708
2021
Q2
$21K Buy
+90
New +$16.1K 0.01% 561

Other funds holding MRNA

Dark Forest Capital Management's MRNA Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 9,262 shares — an estimated $273K sold.

Dark Forest Capital Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $935K in Q3 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 9,262 Moderna shares in Q1 2026, an estimated $273K.
  • Dark Forest Capital Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Dark Forest Capital Management's Moderna position peaked at $935K in Q3 2025.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.